{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:13:37Z","timestamp":1790874817879,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06145-z","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:17:28Z","timestamp":1751429848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohammed","family":"Jemal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn","family":"Abebaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabibal Tsegaye","family":"Workineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worku Abie","family":"Liyew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabarak","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Adugna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"6145_CR1","unstructured":"(WHO) WHO & Hypertension [ (2021). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension"},{"issue":"6","key":"6145_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/QAD.0000000000002171","volume":"33","author":"S Albrecht","year":"2019","unstructured":"Albrecht, S. et al. Age-related comorbidities and mortality in people living with HIV in rural Tanzania. AIDS (London England). 33 (6), 1031\u20131041 (2019).","journal-title":"AIDS (London England)"},{"issue":"10","key":"6145_CR3","doi-asserted-by":"publisher","first-page":"e0204020","DOI":"10.1371\/journal.pone.0204020","volume":"13","author":"AT Brennan","year":"2018","unstructured":"Brennan, A. T. et al. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLOS ONE. 13 (10), e0204020 (2018).","journal-title":"PLOS ONE"},{"issue":"12","key":"6145_CR4","doi-asserted-by":"publisher","first-page":"e0243529","DOI":"10.1371\/journal.pone.0243529","volume":"15","author":"V Pourcher","year":"2020","unstructured":"Pourcher, V., Gourmelen, J., Bureau, I. & Bouee, S. Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France. PLOS ONE. 15 (12), e0243529 (2020).","journal-title":"PLOS ONE"},{"key":"6145_CR5","doi-asserted-by":"crossref","unstructured":"Chhoun, P. et al. High prevalence of non-communicable diseases and associated risk factors amongst adults living with HIV in Cambodia. PLOS ONE 12(11):e0187591. (2017).","DOI":"10.1371\/journal.pone.0187591"},{"key":"6145_CR6","doi-asserted-by":"crossref","unstructured":"Baekken, M., Os, I., Sandvik, L. & Oektedalen, O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. Journal of Hypertension 26(11):2126\u20132133. (2008).","DOI":"10.1097\/HJH.0b013e32830ef5fb"},{"key":"6145_CR7","doi-asserted-by":"crossref","unstructured":"Vecchiet, J. et al. Antihypertensive and metabolic effects of Telmisartan in hypertensive HIV-Positive patients. Antiviral Therapy 16(5):639\u2013645. (2011).","DOI":"10.3851\/IMP1809"},{"key":"6145_CR8","doi-asserted-by":"crossref","unstructured":"Xu, Y., Chen, X. & Wang, K. J. J. A. S. H. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. Journal of the American Society of Hypertension 11(8):530\u2013540. (2017).","DOI":"10.1016\/j.jash.2017.06.004"},{"issue":"1","key":"6145_CR9","first-page":"1","volume":"12","author":"L Gonah","year":"2020","unstructured":"Gonah, L., Moodley, I., Hlongwana, K. W. J. A. J. P. H. C. & Medicine, F. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district. Zimbabwe 12 (1), 1\u20136 (2020).","journal-title":"Zimbabwe"},{"key":"6145_CR10","doi-asserted-by":"crossref","unstructured":"Kagaruki, G. B. et al. Magnitude and risk factors of non-communicable diseases among people living with HIV in tanzania: a cross sectional study from Mbeya and Dar Es Salaam regions.  14:1\u20139. (2014).","DOI":"10.1186\/1471-2458-14-904"},{"key":"6145_CR11","doi-asserted-by":"crossref","unstructured":"Mogaka, J. N. et al. Prevalence and factors associated with hypertension among adults with and without HIV in Western Kenya. PLoS One 17(1):e0262400. (2022).","DOI":"10.1371\/journal.pone.0262400"},{"key":"6145_CR12","doi-asserted-by":"crossref","unstructured":"Hyle, E. P. et al. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan africa: a systematic review. BMC Public Health 17:1\u201315. (2017).","DOI":"10.1186\/s12889-017-4940-1"},{"issue":"3","key":"6145_CR13","first-page":"391","volume":"20","author":"LD Sander","year":"2015","unstructured":"Sander, L. D. et al. Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in R Akai. U Ganda. 20 (3), 391\u2013396 (2015).","journal-title":"U Ganda"},{"key":"6145_CR14","doi-asserted-by":"crossref","unstructured":"Memiah, P. et al. Hypertension and associated inflammatory markers among HIV-infected patients in Tanzania. Journal of Interferon & Cytokine Research 41(8):291\u2013301. (2021).","DOI":"10.1089\/jir.2021.0059"},{"issue":"10","key":"6145_CR15","doi-asserted-by":"publisher","first-page":"e0258576","DOI":"10.1371\/journal.pone.0258576","volume":"16","author":"K Lukas","year":"2021","unstructured":"Lukas, K., Markos, E., Belayneh, F. & Habte, A. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern ethiopia, 2020: A hospital-based cross-sectional study. PLOS ONE. 16 (10), e0258576 (2021).","journal-title":"PLOS ONE"},{"issue":"8","key":"6145_CR16","doi-asserted-by":"publisher","first-page":"e0238114","DOI":"10.1371\/journal.pone.0238114","volume":"15","author":"A Gebrie","year":"2020","unstructured":"Gebrie, A. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest ethiopia: A cross-sectional study. PLOS ONE. 15 (8), e0238114 (2020).","journal-title":"PLOS ONE"},{"key":"6145_CR17","doi-asserted-by":"crossref","unstructured":"Sewale, Y., Afenigus, A. D., Haile, D. & Shiferaw, W. S. Magnitude of hypertension and associated factors among human immunodeficiency virus positive adults receiving Anti-Retroviral therapy at Debre Markos referral hospital (2020)., Northwest, Ethiopia. HIV\/AIDS (Auckland, NZ). HIV AIDS (Auckl) 12:629\u2013637 .","DOI":"10.2147\/HIV.S280630"},{"key":"6145_CR18","doi-asserted-by":"crossref","unstructured":"Lackland, D. T., Keil, J. E., Gazes, P. C., Hames, C. G. & Tyroler, H. A. Outcomes of black and white hypertensive individuals after 30 years of follow-up. Clin. Experimental Hypertens. (New York NY: 1993). 17 (7), 1091\u20131105 (1995).","DOI":"10.3109\/10641969509033654"},{"key":"6145_CR19","unstructured":"Dillon, D. G. et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan africa: a systematic review and meta-analysis. Int J Epidemiol 42(6):1754\u20131771. (2013)."},{"key":"6145_CR20","doi-asserted-by":"crossref","unstructured":"Musekwa, R., Hamooya, B. M., Koethe, J. R., Nzala, S. & Masenga, S. K. J. P. A. M. J. Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone central hospital. Zambia 39(1), 237. (2021).","DOI":"10.11604\/pamj.2021.39.237.29718"},{"key":"6145_CR21","doi-asserted-by":"crossref","unstructured":"Jemal, M. A review of dolutegravir-associated weight gain and secondary metabolic comorbidities. SAGE Open Med 12:20503121241260613. (2024).","DOI":"10.1177\/20503121241260613"},{"key":"6145_CR22","doi-asserted-by":"crossref","unstructured":"Goldberg, R. N., Kania, A. T., Michienzi, S. M., Patel, M. & Badowski, M. E. J. J. I. A. P. A. C. Weight gain in incarcerated individuals living with HIV after switching to integrase strand inhibitor-based therapy. J Int Assoc Provid AIDS Care 20:2325958221996860. (2021).","DOI":"10.1177\/2325958221996860"},{"key":"6145_CR23","doi-asserted-by":"crossref","unstructured":"Leggio, M. et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res 40(12):947\u2013963. (2017).","DOI":"10.1038\/hr.2017.75"},{"key":"6145_CR24","doi-asserted-by":"crossref","unstructured":"Kamal, P. & Sharma, S. J. J. E. S. SUN-187 dolutegravir causing diabetes. ;3(Supplement_1):SUN-187. (2019).","DOI":"10.1210\/js.2019-SUN-187"},{"issue":"1","key":"6145_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12879-023-08892-8","volume":"24","author":"VJ Kigongo","year":"2024","unstructured":"Kigongo, V. J. et al. Dyslipidemia among adult people living with HIV on dolutegravir - based antiretroviral therapy at a private tertiary hospital in kampala, uganda: burden and determinants. BMC Infect. Dis. 24 (1), 53 (2024).","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"6145_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie, J. R., Guzik, T. J. & Touyz, R. M. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can. J. Cardiol. 34 (5), 575\u2013584 (2018).","journal-title":"Can. J. Cardiol."},{"key":"6145_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/IBPC.S403023","volume":"16","author":"R Kasoma Mutebi","year":"2023","unstructured":"Kasoma Mutebi, R. et al. Prevalence of and factors associated with hypertension among adults on Dolutegravir-Based antiretroviral therapy in uganda: A cross sectional study. Integr. Blood Press. Control. 16, 11\u201321 (2023).","journal-title":"Integr. Blood Press. Control"},{"issue":"3","key":"6145_CR28","doi-asserted-by":"publisher","first-page":"ofae061","DOI":"10.1093\/ofid\/ofae061","volume":"11","author":"M Lartey","year":"2024","unstructured":"Lartey, M. et al. Hypertension among cohort of persons with human immunodeficiency virus initiated on a Dolutegravir-Based antiretroviral regimen in Ghana. Open. Forum Infect. Dis. 11 (3), ofae061 (2024).","journal-title":"Open. Forum Infect. Dis."},{"key":"6145_CR29","unstructured":"FMoHo, E. J. G. W. H. O. National consolidated guidelines for comprehensive HIV prevention, care and treatment. (2020)."},{"key":"6145_CR30","unstructured":"Organization, W. H. STEPwise approach to NCD risk factor surveillance (STEPS) Geneva: World Health Organization; [ (2012). Available from: https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps"},{"issue":"3","key":"6145_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall, F. Q. Body mass index: obesity, BMI, and health: A critical review. Nutr. Today. 50 (3), 117\u2013128 (2015).","journal-title":"Nutr. Today"},{"key":"6145_CR32","unstructured":"Consultation WEJRoaWECGWHO. Waist circumference and waist-hip ratio. 2008:8\u201311. (2008)."},{"issue":"33","key":"6145_CR33","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur. Heart J. 39 (33), 3021\u20133104 (2018).","journal-title":"Eur. Heart J."},{"issue":"12","key":"6145_CR34","doi-asserted-by":"publisher","first-page":"e0279580","DOI":"10.1371\/journal.pone.0279580","volume":"17","author":"A Beyene Kassaw","year":"2022","unstructured":"Beyene Kassaw, A., Tezera Endale, H., Hunie Tesfa, K. & Derbew Molla, M. Metabolic syndrome and its associated factors among epileptic patients at Dessie comprehensive specialized hospital, Northeast ethiopia; a hospital-based comparative cross-sectional study. PLoS One. 17 (12), e0279580 (2022).","journal-title":"PLoS One"},{"key":"6145_CR35","unstructured":"EPH A. On Alcohol, Substance, Khat and Tobacco. 22nd Annual Conference of EPHAApril 2012."},{"issue":"3","key":"6145_CR36","first-page":"A89","volume":"5","author":"F Tesfaye","year":"2008","unstructured":"Tesfaye, F., Byass, P., Wall, S., Berhane, Y. & Bonita, R. Association of smoking and Khat (Catha Edulis Forsk) use with high blood pressure among adults in addis ababa, ethiopia, 2006. Prev. Chronic Dis. 5 (3), A89 (2008).","journal-title":"Prev. Chronic Dis."},{"key":"6145_CR37","unstructured":"Manual FMoHJP. National Comprehensive HIV Prevention, Care and Treatment Training for Health care Providers. :1-123. (2018)."},{"issue":"1","key":"6145_CR38","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.1038\/s41598-024-64212-3","volume":"14","author":"CO Assogba","year":"2024","unstructured":"Assogba, C. O. et al. Prevalence and associated factors of hypertension among people living with HIV\/AIDS on antiretroviral therapy in benin\u2019s National teaching hospital. Sci. Rep. 14 (1), 17035 (2024).","journal-title":"Sci. Rep."},{"key":"6145_CR39","doi-asserted-by":"crossref","unstructured":"Hirigo, A. T., Yilma, D., Astatkie, A. & Debebe, Z. The association between dolutegravir-based antiretrovirals and high blood pressure among adults with HIV in Southern ethiopia: a cross-sectional study. Ther Adv Infect Dis 11:20499361241306942. (2024).","DOI":"10.1177\/20499361241306942"},{"key":"6145_CR40","doi-asserted-by":"crossref","unstructured":"Mulugeta, H. et al. Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study. HIV\/AIDS (Auckland, NZ). ;13:889\u2013901. (2021).","DOI":"10.2147\/HIV.S329838"},{"key":"6145_CR41","unstructured":"Venter, W. (ed) Risks of hypertension with first-line dolutegravir and tenofovir alafenamide in the NAMSAL and ADVANCE trials-OALBB05. 12th IAS Conference on HIV Science Brisbane, Australia; (2023)."},{"issue":"1","key":"6145_CR42","first-page":"5544916","volume":"2021","author":"GW Mbuthia","year":"2021","unstructured":"Mbuthia, G. W., Magutah, K. & McGarvey, S. T. The prevalence and associated factors of hypertension among HIV patients. Int. J. Hypertens. 2021 (1), 5544916 (2021).","journal-title":"Int. J. Hypertens."},{"issue":"1","key":"6145_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12981-023-00576-2","volume":"21","author":"MKI Denu","year":"2024","unstructured":"Denu, M. K. I., Revoori, R., Buadu, M. A. E., Oladele, O. & Berko, K. P. Hypertension among persons living with HIV\/AIDS and its association with HIV-related health factors. AIDS Res. Therapy. 21 (1), 5 (2024).","journal-title":"AIDS Res. Therapy"},{"issue":"1","key":"6145_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12872-023-03332-6","volume":"23","author":"TM Mwakyandile","year":"2023","unstructured":"Mwakyandile, T. M. et al. Hypertension and traditional risk factors for cardiovascular diseases among treatment Na\u00efve HIV- infected adults initiating antiretroviral therapy in urban Tanzania. BMC Cardiovasc. Disord. 23 (1), 309 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"6145_CR45","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1002\/hsr2.372","volume":"4","author":"E Tesfa","year":"2021","unstructured":"Tesfa, E. & Demeke, D. Prevalence of and risk factors for hypertension in ethiopia: A systematic review and meta-analysis. Health Sci. Rep. 4 (3), e372 (2021).","journal-title":"Health Sci. Rep."},{"issue":"3","key":"6145_CR46","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0008-6363(01)00527-2","volume":"53","author":"RK Dubey","year":"2002","unstructured":"Dubey, R. K., Oparil, S., Imthurn, B. & Jackson, E. K. Sex hormones and hypertension. Cardiovascular. Res. 53 (3), 688\u2013708 (2002).","journal-title":"Cardiovascular. Res."},{"key":"6145_CR47","doi-asserted-by":"crossref","unstructured":"Reckelhoff, J. F. J. H. Gender differences in the regulation of blood pressure. Hypertension 37(5):1199\u20131208. (2001).","DOI":"10.1161\/01.HYP.37.5.1199"},{"key":"6145_CR48","doi-asserted-by":"crossref","first-page":"2235042x1989931","DOI":"10.1177\/2235042X19899319","volume":"10","author":"Z Getahun","year":"2020","unstructured":"Getahun, Z., Azage, M., Abuhay, T. & Abebe, F. Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar City. Ethiopia J. Comorbidity. 10, 2235042x19899319 (2020).","journal-title":"Ethiopia J. Comorbidity"},{"key":"6145_CR49","doi-asserted-by":"crossref","unstructured":"McGettrick, P., Alvarez Barco, E. & Mallon, P. W. (eds) Ageing with HIV (MDPI, 2018).","DOI":"10.3390\/healthcare6010017"},{"key":"6145_CR50","doi-asserted-by":"crossref","unstructured":"Tsuro, U., Oladimeji, K. E., Pulido-Estrada, G. A. & Apalata, T. R. Risk factors attributable to hypertension among HIV-Infected patients on antiretroviral therapy in selected rural districts of the Eastern cape province, South Africa. Int. J. Environ. Res. Public Health 19(18). (2022).","DOI":"10.3390\/ijerph191811196"},{"key":"6145_CR51","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2147\/VHRM.S442108","volume":"19","author":"D Uwanyirigira","year":"2023","unstructured":"Uwanyirigira, D. et al. Prevalence and factors associated with hypertension among HIV positive patients on antiretroviral therapy: A Hospital-Based Cross-Sectional study in Rwanda. Vasc. Health Risk Manag. 19, 857\u2013870 (2023).","journal-title":"Vasc. Health Risk Manag."},{"key":"6145_CR52","doi-asserted-by":"publisher","first-page":"1173440","DOI":"10.3389\/fcvm.2023.1173440","volume":"10","author":"AS Badacho","year":"2023","unstructured":"Badacho, A. S. & Mahomed, O. H. Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia. Front. Cardiovasc. Med. 10, 1173440 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"6145_CR53","doi-asserted-by":"crossref","unstructured":"Haile, M., Degelo, T., Adilo, T. M., Adem, F. M. & Gidisa, B. Prevalence of Hypertension and Its Associated Factors Among Adults Living with HIV on Antiretroviral Treatment in Selected Public Hospitals in Addis Ababa, Ethiopia. HIV\/AIDS (Auckland, NZ). ;16:109\u2009\u2013\u200922. (2024).","DOI":"10.2147\/HIV.S447396"},{"key":"6145_CR54","doi-asserted-by":"crossref","unstructured":"Tozawa, M. et al. Family history of hypertension and blood pressure in a screened cohort. Hypertens Res 24(2):93\u201398. (2001).","DOI":"10.1291\/hypres.24.93"},{"issue":"1","key":"6145_CR55","doi-asserted-by":"publisher","first-page":"20509","DOI":"10.1038\/s41598-022-24997-7","volume":"12","author":"D Harimenshi","year":"2022","unstructured":"Harimenshi, D., Niyongabo, T., Preux, P. M., Aboyans, V. & Desormais, I. Hypertension and associated factors in HIV-infected patients receiving antiretroviral treatment in burundi: a cross-sectional study. Sci. Rep. 12 (1), 20509 (2022).","journal-title":"Sci. Rep."},{"issue":"12","key":"6145_CR56","doi-asserted-by":"publisher","first-page":"21630","DOI":"10.1002\/jcp.28821","volume":"234","author":"D Ferrara","year":"2019","unstructured":"Ferrara, D., Montecucco, F., Dallegri, F. & Carbone, F. Impact of different ectopic fat depots on cardiovascular and metabolic diseases. J. Cell. Physiol. 234 (12), 21630\u201321641 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"16","key":"6145_CR57","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1001\/jama.2010.1505","volume":"304","author":"BH Goodpaster","year":"2010","unstructured":"Goodpaster, B. H. et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. Jama 304 (16), 1795\u20131802 (2010).","journal-title":"Jama"},{"key":"6145_CR58","doi-asserted-by":"crossref","unstructured":"Menard, A. et al. effect? Dolutegravir and weight gain: an unexpected bothering side. AIDS 31(10):1499\u20131500. (2017).","DOI":"10.1097\/QAD.0000000000001495"},{"key":"6145_CR59","doi-asserted-by":"publisher","first-page":"205031212210944","DOI":"10.1177\/20503121221094454","volume":"10","author":"BT Zewudie","year":"2022","unstructured":"Zewudie, B. T. et al. The magnitude of undiagnosed hypertension and associated factors among HIV-positive patients attending antiretroviral therapy clinics of Butajira general hospital, gurage zone, Southern Ethiopia. SAGE Open. Med. 10, 20503121221094454 (2022).","journal-title":"SAGE Open. Med."},{"key":"6145_CR60","doi-asserted-by":"publisher","first-page":"4103604","DOI":"10.1155\/2019\/4103604","volume":"2019","author":"T Fiseha","year":"2019","unstructured":"Fiseha, T., Belete, A. G., Dereje, H. & Dires, A. Hypertension in HIV-Infected patients receiving antiretroviral therapy in Northeast Ethiopia. Int. J. Hypertens. 2019, 4103604 (2019).","journal-title":"Int. J. Hypertens."},{"key":"6145_CR61","first-page":"e15","volume":"39","author":"Y Tatsumi","year":"2021","unstructured":"Tatsumi, Y. et al. SAKU STUDY 39:e15\u2013e6. (2021).","journal-title":"SAKU STUDY"},{"issue":"1","key":"6145_CR62","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12879-023-08679-x","volume":"23","author":"KD Tegegne","year":"2023","unstructured":"Tegegne, K. D. et al. Prevalence and factors associated with hypertension among peoples living with HIV in East africa, a systematic review and meta-analysis. BMC Infect. Dis. 23 (1), 724 (2023).","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"6145_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","volume":"14","author":"BM Cheung","year":"2012","unstructured":"Cheung, B. M. & Li, C. Diabetes and hypertension: is there a common metabolic pathway? Curr. Atheroscler. Rep. 14 (2), 160\u2013166 (2012).","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06145-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:17:39Z","timestamp":1751429859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06145-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6145"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06145-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23267"}}